350 related articles for article (PubMed ID: 29702194)
1. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
Yu F; Liu JB; Wu ZJ; Xie WT; Zhong XJ; Hou LK; Wu W; Lu HM; Jiang XH; Jiang JJ; Cao ZY; Cong GJ; Shi MX; Jia CY; Lu GX; Song YC; Chai L; Lv ZW; Wu CY; Ma YS; Fu D
Cancer Lett; 2018 Jul; 427():74-84. PubMed ID: 29702194
[TBL] [Abstract][Full Text] [Related]
2. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.
Ma YS; Yu F; Zhong XM; Lu GX; Cong XL; Xue SB; Xie WT; Hou LK; Pang LJ; Wu W; Zhang W; Cong LL; Liu T; Long HD; Sun R; Sun HY; Lv ZW; Wu CY; Fu D
Mol Ther; 2018 Dec; 26(12):2751-2765. PubMed ID: 30301667
[TBL] [Abstract][Full Text] [Related]
3. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Hu S; Yuan Y; Song Z; Yan D; Kong X
Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth.
Zhang L; Xu B; Qiang Y; Huang H; Wang C; Li D; Qian J
J Cell Mol Med; 2015 Apr; 19(4):799-805. PubMed ID: 25656529
[TBL] [Abstract][Full Text] [Related]
5. Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib.
Wang C; Ding S; Sun B; Shen L; Xiao L; Han Z; Huang H
Pharmacol Res; 2020 Nov; 161():105110. PubMed ID: 32755614
[TBL] [Abstract][Full Text] [Related]
6. MiR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Wu N; Zhang C; Bai C; Han YP; Li Q
Cell Physiol Biochem; 2014; 33(2):457-67. PubMed ID: 24556800
[TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
8. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
9. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells.
Chandimali N; Huynh DL; Zhang JJ; Lee JC; Yu DY; Jeong DK; Kwon T
Cancer Gene Ther; 2019 Sep; 26(9-10):292-304. PubMed ID: 30341415
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
Wang N; Zhang T
Oncol Res; 2018 Aug; 26(7):1005-1014. PubMed ID: 29295721
[TBL] [Abstract][Full Text] [Related]
12. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
Jin S; He J; Li J; Guo R; Shu Y; Liu P
Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
[TBL] [Abstract][Full Text] [Related]
13. miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met.
Cao X; Lai S; Hu F; Li G; Wang G; Luo X; Fu X; Hu J
Sci Rep; 2017 Jun; 7(1):2939. PubMed ID: 28592790
[TBL] [Abstract][Full Text] [Related]
14. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.
Tang X; Jiang J; Zhu J; He N; Tan J
Mol Genet Genomics; 2019 Feb; 294(1):85-93. PubMed ID: 30196354
[TBL] [Abstract][Full Text] [Related]
15. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.
Kim G; An HJ; Lee MJ; Song JY; Jeong JY; Lee JH; Jeong HC
Lung Cancer; 2016 Jan; 91():15-22. PubMed ID: 26711929
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
Narita M; Shimura E; Nagasawa A; Aiuchi T; Suda Y; Hamada Y; Ikegami D; Iwasawa C; Arakawa K; Igarashi K; Kuzumaki N; Yoshioka Y; Ochiya T; Takeshima H; Ushijima T; Narita M
PLoS One; 2017; 12(2):e0172115. PubMed ID: 28225782
[TBL] [Abstract][Full Text] [Related]
19. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
20. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]